<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer

dc.contributor.authorPanieri, Emiliano
dc.contributor.authorTelkoparan-Akillilar, Pelin
dc.contributor.authorSaso, Luciano
dc.date.accessioned2026-10-09T21:46:39Z
dc.date.issued2023
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractThe skin represents a physical barrier between the organism and the environment that has evolved to confer protection against biological, chemical, and physical insults. The inner layer, known as dermis, is constituted by connective tissue and different types of immune cells whereas the outer layer, the epidermis, is composed by different layers of keratinocytes and an abundant number of melanocytes, localized in the stratum basale of the epidermis. Oxidative stress is a common alteration of inflammatory skin disorders such as vitiligo, dermatitis, or psoriasis but can also play a causal role in skin carcinogenesis and tumor progression. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) has emerged as a crucial regulator of cell defense mechanisms activating complex transcriptional programs that facilitate reactive oxygen species detoxification, repair oxidative damage and prevent xenobiotic-induced toxicity. Accumulating evidence suggests that the keratinocytes, melanocytes, and other skin cell types express high levels of NRF2, which is known to play a pivotal role in the skin homeostasis, differentiation, and metabolism during normal and pathologic conditions. In the present review, we summarize the current evidence linking NRF2 to skin pathophysiology and we discuss some recent modulators of NRF2 activity that have shown a therapeutic efficacy in skin protection against tumor initiation and common inflammatory skin conditions such as vitiligo or psoriasis, with a particular emphasis on natural compounds.
dc.identifier.doi10.1002/biof.1912
dc.identifier.endpage250
dc.identifier.issn0951-6433
dc.identifier.issn1872-8081
dc.identifier.issue2
dc.identifier.orcid0000-0001-7989-7145
dc.identifier.orcid0000-0003-4530-8706
dc.identifier.orcid0000-0003-0337-0763
dc.identifier.pmid36310374
dc.identifier.scopus2-s2.0-85141150433
dc.identifier.scopusqualityQ1
dc.identifier.startpage228
dc.identifier.urihttps://doi.org/10.1002/biof.1912
dc.identifier.urihttps://hdl.handle.net/20.500.12794/3393
dc.identifier.volume49
dc.identifier.wosWOS:000876135100001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.digerScience Citation Index Expanded (SCI-EXPANDED)
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofBiofactors
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260922
dc.subjectPhase-Ii Detoxification
dc.subjectFumaric-Acid Esters
dc.subjectControlling Inducible Expression
dc.subjectMethionine-Sulfoxide-Reductase
dc.subjectMouse Peritoneal-Macrophages
dc.subjectLps-Induced Inflammation
dc.subjectInduced Oxidative Stress
dc.subjectChronic Plaque Psoriasis
dc.subjectCul3-Based E3 Ligase
dc.subjectYa Subunit Gene
dc.titleNRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer
dc.typeReview Article

Files